Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer": An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal

Bram L. T. Ramaekers*, Rob Riemsma, Florian Tomini, Thea van Asselt, Sohan Deshpande, Steven Duffy, Nigel Armstrong, Johan L. Severens, Jos Kleijnen, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)665-667
Number of pages3
JournalPharmacoeconomics
Volume35
Issue number6
DOIs
Publication statusPublished - Jun 2017

Cite this

@article{2c1f3b6353da4c0cb991aab048ef4c47,
title = "Response to Letter to the Editor Regarding {"}Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer{"}: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal",
author = "Ramaekers, {Bram L. T.} and Rob Riemsma and Florian Tomini and {van Asselt}, Thea and Sohan Deshpande and Steven Duffy and Nigel Armstrong and Severens, {Johan L.} and Jos Kleijnen and Joore, {Manuela A.}",
year = "2017",
month = "6",
doi = "10.1007/s40273-017-0507-3",
language = "English",
volume = "35",
pages = "665--667",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "6",

}

Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer" : An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal. / Ramaekers, Bram L. T.; Riemsma, Rob; Tomini, Florian; van Asselt, Thea; Deshpande, Sohan; Duffy, Steven; Armstrong, Nigel; Severens, Johan L.; Kleijnen, Jos; Joore, Manuela A.

In: Pharmacoeconomics, Vol. 35, No. 6, 06.2017, p. 665-667.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

TY - JOUR

T1 - Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer"

T2 - An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal

AU - Ramaekers, Bram L. T.

AU - Riemsma, Rob

AU - Tomini, Florian

AU - van Asselt, Thea

AU - Deshpande, Sohan

AU - Duffy, Steven

AU - Armstrong, Nigel

AU - Severens, Johan L.

AU - Kleijnen, Jos

AU - Joore, Manuela A.

PY - 2017/6

Y1 - 2017/6

U2 - 10.1007/s40273-017-0507-3

DO - 10.1007/s40273-017-0507-3

M3 - Comment/Letter to the editor

VL - 35

SP - 665

EP - 667

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 6

ER -